Veraxa Biotech (VRXA) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 70 249 sessions, October 30, 2025 to October 30, 2026
- Largest daily move
- -55.5% close of June 16, 2026
- 1-year change
- -89.1% closing prices, October 30, 2025 to October 30, 2026
- 1-month change
- -8.8% closing prices, September 30, 2026 to October 30, 2026
Company Description
Veraxa Biotech (NASDAQ: VRXA) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $158.4M.
VRXA has declined 89.1% over the past year. The last closing price was $1.14.
This page collects what Stock Titan holds for VRXA, including price data, latest news, SEC filings, insider trading activity, upcoming events, and short interest trends.
Stock Performance
Veraxa Biotech (VRXA) closed at $1.14 on October 30, 2026. Over the past 12 months, the price has lost 89.1%.
VRXA Metrics & Rankings
Price returns through October 30, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Veraxa Biotech has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include partnership, AI. View all VRXA news →
SEC Filings
Veraxa Biotech has filed 10 recent SEC filings, including 4 Form 4, 3 Form 6-K, 2 Form 424B3, 1 Form 3. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VRXA SEC filings →
Insider Radar
Insider buying activity at Veraxa Biotech over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
VXA-102 IND/CTA readiness
Capital band expiry
Veraxa Biotech has 2 upcoming scheduled events. The next event, "VXA-102 IND/CTA readiness", is scheduled for January 1, 2028 (in 427 days). Investors can track these dates to stay informed about potential catalysts that may affect the VRXA stock price.
Short Interest History
Short interest in Veraxa Biotech (VRXA) currently stands at 235.0 thousand shares, up 12.1% from the previous reporting period, representing 0.6% of the float. Since June 2026, short interest has increased by 2209.5%.
Days to Cover History
Days to cover for Veraxa Biotech (VRXA) currently stands at 4.6 days, up 357% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since June 2026, the figure has increased by 339.4%. Across the settlements charted above, it has ranged from 1.0 to 4.6 days.
VRXA Company Profile & Sector Positioning
Veraxa Biotech (VRXA) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.